Cogent Biosciences COGT
NASDAQ COGT
$29.53 -2.11 (-6.67%)
As of: Nov 11, 2026 · 12:38 PM EST

Cogent Biosciences (COGT) Invested Capital (2024 - 2025)

Updated

Cogent Biosciences (COGT) posted Invested Capital of $346.71 million for Q3 2025, up 74.2% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Invested Capital (2024 - 2025) Analysis & Trends

For FY2024, Cogent Biosciences' Invested Capital came in at $256.29 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Cogent Biosciences 5.50 Bn 2.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 346.71 Mn
Jun 30, 2025 198.99 Mn
Dec 31, 2024 256.29 Mn
API Access

Cogent Biosciences Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=COGT&period=max&api_key=YOUR_API_KEY